Stockscreener 앱 받기
21.71
1.45%
-0.32
시장 영업 전:
21.56
-0.15
-0.69%
전일 마감가:
$22.03
열려 있는:
$22.27
하루 거래량:
852.66K
Relative Volume:
0.82
시가총액:
$1.61B
수익:
-
순이익/손실:
$-107.85M
주가수익비율:
-9.8235
EPS:
-2.21
순현금흐름:
$-106.82M
1주 성능:
-14.22%
1개월 성능:
-1.41%
6개월 성능:
-54.86%
1년 성능:
-48.71%
1일 변동 폭
$21.66
$23.18
1주일 범위
$21.00
$25.84
52주 변동 폭
$18.53
$51.61
베라 테라 Stock (VERA) Company Profile
명칭
Vera Therapeutics Inc
전화
650-770-0077
주소
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
VERA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
21.71 | 1.61B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
베라 테라 Stock (VERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 재개 | H.C. Wainwright | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2025-01-28 | 개시 | Goldman | Buy |
| 2024-11-21 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-25 | 개시 | Oppenheimer | Outperform |
| 2024-01-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-12-18 | 개시 | Raymond James | Outperform |
| 2023-11-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-16 | 개시 | Guggenheim | Buy |
| 2023-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-04 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-12 | 개시 | JP Morgan | Overweight |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2022-04-19 | 개시 | Wedbush | Outperform |
모두보기
베라 테라 주식(VERA)의 최신 뉴스
FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World
Q2 EPS Forecast for Vera Therapeutics Reduced by Analyst - Defense World
Q2 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World
Hsbc Holdings PLC Takes $264,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter
Cantor Fitzgerald Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $100.00 - Defense World
Wedbush Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $26.00 - Defense World
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
What is Wedbush’s Estimate for VERA Q1 Earnings? - Defense World
Analysts Set Expectations for VERA Q2 Earnings - Defense World
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Vera Therapeutics (VERA) and Dexcom (DXCM) - The Globe and Mail
Analysts Issue Forecasts for VERA Q1 Earnings - Defense World
Decoding Vera Therapeutics Inc (VERA): A Strategic SWOT Insight - GuruFocus
Ratios Reveal: Breaking Down Vera Therapeutics Inc (VERA)’s Financial Health - DWinneX
Vera Therapeutics (VERA) Price Target Adjusted by Cantor Fitzgerald | VERA Stock News - GuruFocus
Vera Therapeutics Advances Atacicept in Key Trials - TipRanks
Vera Therapeutics shares fall as Q1 loss exceeds estimates By Investing.com - Investing.com Nigeria
Vera Therapeutics shares fall as Q1 loss exceeds estimates - Investing.com Australia
Medtronic gains after boosting full-year guidance By Investing.com - Investing.com India
Vera Therapeutics reports Q1 EPS (81c), consensus (78c) - TipRanks
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Vera Therapeutics' Q1 Net Loss Widens - marketscreener.com
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept - GuruFocus
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept | VERA Stock News - GuruFocus
Earnings Flash (VERA) Vera Therapeutics Posts Q1 Net Loss $0.81 a Share, vs. FactSet Est of $0.75 Loss - marketscreener.com
Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results - The Manila Times
BRIEF-Vera Therapeutics Q1 EPS USD -0.81 Vs. IBES Estimate USD -0.74 - TradingView
Vera Therapeutics Nears Critical Phase 3 Readout with $589M War Chest for IgAN Drug Launch - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Coverage Initiated by Analysts at HC Wainwright - Defense World
Vera Therapeutics (VERA) Gains Positive Outlook with Buy Rating - GuruFocus
Vera Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
Vera Therapeutics (VERA) Receives New Buy Rating from HC Wainwri - GuruFocus
(VERA) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Vera Therapeutics Inc (VERA) - Sete News
Vera Therapeutics Inc (VERA) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Insider’s View: Deciphering Vera Therapeutics Inc (VERA)’s Financial Health Through Ratios - DWinneX
Vera Therapeutics Inc (VERA)’s stock performance: a year in review - uspostnews.com
Vera Therapeutics (VERA) Expected to Announce Earnings on Thursday - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Vera Therapeutics Inc (VERA) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MN - Defense World
A stock that deserves closer examination: Vera Therapeutics Inc (VERA) - uspostnews.com
Traders Purchase Large Volume of Call Options on Vera Therapeutics (NASDAQ:VERA) - Defense World
Vera Therapeutics Inc (VERA): What Are The Positives? - Marketing Sentinel
When (VERA) Moves Investors should Listen - news.stocktradersdaily.com
Vera Therapeutics Inc (NASDAQ: VERA) Received An -47.05% Loss In 6 Months – Here’s What To Expect - Marketing Sentinel
Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph
After-Market Momentum Builds For ASP Isotopes (ASPI) Amid Secondary Listing News - Stocks Telegraph
Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World
베라 테라 (VERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
0.15%
자본화:
|
볼륨(24시간):